Loading
  1. Lunch Break
  2. Lunch Break
  3. Lunch Break
Main Stage
  1. The Future for Genomics and the NHS Shaped by New Government Strategies
    Main Stage
    Speakers
    Dame Sue Hill
    Dame Sue Hill, Chief Scientific Officer - NHS England
  2. Evaluating Constellation: Insights into NHS Paediatric Acute Care Pathways
    Main Stage
    Speakers
    Andrew Parrish
    Andrew Parrish, Rare and Inherited Disease NHS Genomic Network of Excellence - Exeter Genomics Laboratory (South West GLH), Royal Devon University Healthcare NHS Foundation Trust
    Emma Baple
    Emma Baple, Professor of Genomic Medicine - University of Exeter
    Richard Capper
    Richard Capper, Senior Director of Global Research Customer Segment Marketing - Illumina
  3. Panel Discussion: Practical Strategies to Deliver the Next Decade of UK Health and Care – What’s Next for Our NHS?
    Main Stage
    Speakers
    Dame Sue Hill
    Dame Sue Hill, Chief Scientific Officer - NHS England
    Richard Scott
    Richard Scott, Chief Executive Officer - Genomics England
    Suzanne Rankin
    Suzanne Rankin, Chief Executive Officer - Cardiff and Vale University Health Board
  4. Hope, Perseverance, and the Promise of Advanced Therapies
    Main Stage
    Speakers
    Funmi Vanessa Ullam
    Funmi Vanessa Ullam, Parent of a Child with a Chronic Condition
  5. Networking Break
    Main Stage
  6. Nanopore Sequencing to Understand and Diagnose Brain Tumours
    Main Stage
    Speakers
    Matthew Loose
    Matthew Loose, Academic Lead of DeepSeq - University of Nottingham
  7. Sequencing of the UK biobank using Oxford Nanopore
    Main Stage
    Speakers
    Bjarni V. Halldórsson
    Bjarni V. Halldórsson, Principal Investigator - deCODE
  8. Panel Discussion: From Precision Medicine to Precision Analysis: Integrating Long-Reads as a Frontline Diagnostic
    Main Stage
    Speakers
    Anna Lindstrand
    Anna Lindstrand, Director of the Clinical Genetics Diagnostic Laboratory - Karolinska University Hospital
    Christopher Watson
    Christopher Watson, Associate Professor of Molecular Diagnostics - University of Leeds
    Andrew Beggs
    Andrew Beggs, Professor of Cancer Genetics & Surgery - University of Birmingham
  9. Lunch Break
    Main Stage
  10. Long-read Sequencing for the Diagnosis of Primary Mitochondrial DNA Disorders
    Main Stage
    Speakers
    Robert Pitceathly
    Robert Pitceathly, Professor of Clinical Neurology and Mitochondrial Medicine - University College London
  11. New Frontiers – HiFi Sequencing Technology Updates
    Main Stage
    Speakers
    Neil Ward
    Neil Ward, VP & GM EMEA - PacBio
    Mohammed Uddin
    Mohammed Uddin, Director - Centre for Applied and Translational Genomics
  12. The Potential of Long-Reads to Uncover New Therapeutic Targets
    Main Stage
    Speakers
    Wilfried Haerty
    Wilfried Haerty, Group Leader - Earlham Institute
  13. Networking Break
    Main Stage
  14. The Evolving Sequencing Landscape: How All the New Technologies Stack Up
    Main Stage
    Speakers
    Michael Quail
    Michael Quail, Principal Scientist - R&D Sequencing - Wellcome Sanger Institute 
  15. Tumor-informed WGS-based ctDNA Detection
    Main Stage
    Speakers
    Edwin Cuppen
    Edwin Cuppen, Scientific director - Hartwig Medical foundation
  16. Long-Read Sequencing: Enabling High-Resolution Population and Medical Genomics
    Main Stage
    Speakers
    Adam Ameur
    Adam Ameur, Associate Professor of Genomics and Bioinformatics - Uppsala University
Biodata Stage
  1. Panel Discussion: Can We Move From Silos to Systems to Scale Biodata for a Borderless Future?
    Biodata Stage
    Speakers
    Nathalie Conte
    Nathalie Conte, R&D Lead for FAIR data integration - AstraZeneca
    Helen Parkinson
    Helen Parkinson, Section Head, Team Leader and Senior Scientist -  EMBL-EBI
    Natalie Twine
    Natalie Twine, Senior Research Scientist - CSIRO 
  2. Modern Genomics Pipelines: Smarter Development, Faster Science
    Biodata Stage
    Speakers
    Geraldine Van der Auwera
    Geraldine Van der Auwera, Lead Developer Advocate - Seqera
  3. Unlocking UK Biobank’s Data Potential
    Biodata Stage
    Speakers
    Mark Effingham
    Mark Effingham, Deputy CEO - UK Biobank
    Matthew Loose
    Matthew Loose, Academic Lead of DeepSeq - University of Nottingham
    Scott Ritchie
    Scott Ritchie, Assistant Professor of Research - University of Cambridge
  4. Lunch Break
    Biodata Stage
  5. Helping Everyone Live Longer and Healthier Lives: The Our Future Health Data Set and Its Potential for Research
    Biodata Stage
    Speakers
    Adam Steventon
    Adam Steventon, Interim Chief Data Officer - Our Future Health
  6. Curate to Innovate: Why AI in Genomics Needs Expert Data Foundations
    Biodata Stage
    Speakers
    Jane Lomax
    Jane Lomax, Head of Terminology Services - Rancho Biosciences
  7. The Federated European Genome-Phenome Archive: Enabling Global Access to Human Genomics Data
    Biodata Stage
    Speakers
    Mallory Freeberg
    Mallory Freeberg, Human Genomics Team Leader - EMBL-EBI 
  8. Networking Break
    Biodata Stage
  9. From UGR to the Single Patient Record: Building National-Scale Genomic Integration in the NHS
    Biodata Stage
    Speakers
    Deborah Porter
    Deborah Porter, Deputy Director Genomics Service Transformation - NHS England
  10. Scaling the UKs National Biobanks: How AWS Supports Genomics England, UK Biobank, and NIHR BioResource
    Biodata Stage
    Speakers
    Mark Conway
    Mark Conway, CTO - UK Biobank
    Andrew Leedham
    Andrew Leedham, Head of Research Data and Technology - NIHR BioResource
    Julian Thomas
    Julian Thomas, Chief Technology and Product Officer - Genomics England
    Ankit Malhotra
    Ankit Malhotra, Global Head of Genomics, Strategy and Solutions - AWS
  11. Advancing Data Stewardship: Challenges, FAIR and ELIXIR-UK Communities
    Biodata Stage
    Speakers
    Robert Andrews
    Robert Andrews,  UK RDM Club Lead - ELIXIR-UK
Single-Cell Stage
  1. Decoding Phenotypes at the Cell Type Level
    Single-Cell Stage
    Speakers
    Irene Papatheodorou
    Irene Papatheodorou, Head of Data Science - Earlham Institute
  2. Complementary, scalable single-cell and spatial profiling to reveal deeper biological insights
    Single-Cell Stage
    Speakers
    Sarah Taylor
    Sarah Taylor, Head of Business Development - 10x Genomics
  3. Therapeutic Antibody Discovery From Disease-Resilient Individuals Through Bulk and Single Cell Immune Repertoire Sequencing
    Single-Cell Stage
    Speakers
    David Yadin
    David Yadin,  Associate Director, Research -  Alchemab Therapeutics
  4. Lunch Break
    Single-Cell Stage
  5. Leveraging single-cell transcriptomics for ALS disease model characterisation and mechanistic insights
    Single-Cell Stage
    Speakers
    Harpreet Saini
    Harpreet Saini, Senior Director, Bioinformatics - Astex Pharmaceuticals 
  6. A Scalable Platform for Single-Cell Co-Profiling of the Transcriptome and Genotype
    Single-Cell Stage
    Speakers
    Jan Bergmann
    Jan Bergmann, Head of Computational Biology - Atrandi Biosciences
  7. Decoding Human Variation at Single-Cell Resolution: Genetic Insights from the TenK10K Atlas
    Single-Cell Stage
    Speakers
    Anna Cuomo
    Anna Cuomo, Associate Principal Scientist -  AstraZeneca 
  8. Networking Break
    Single-Cell Stage
  9. Building AI Models for Single-Cell Multi-Modal Integration
    Single-Cell Stage
    Speakers
    Alejandro Sifrim
    Alejandro Sifrim, Group Leader - University of Leuven 
  10. Uncovering the origin of tumor heterogeneity in Pediatric High-Grade gliomas using novel human organoid models
    Single-Cell Stage
    Speakers
    Roxy Finger
    Roxy Finger, PhD Student - Princes Maxima Center, Utrecht University
    Richard Capper
    Richard Capper, Senior Director of Global Research Customer Segment Marketing - Illumina
  11. Single Cell Multiomic Profiling Reveals Mechanisms of Resistance in Triple Negative Breast Cancer
    Single-Cell Stage
    Speakers
    Syed Haider
    Syed Haider, Team Leader, Breast Cancer Research Data Science Group - Institute of Cancer Research
Spatial Stage
  1. Spatial Profiling at Scale: Where Are We Now and What Comes Next?
    Spatial Stage
    Speakers
    Jasmine Plummer
    Jasmine Plummer, Director, Center for Spatial OMICs - St Jude Children's Research Hospital
  2. Redefining Sequencing: FromGenomics to 5D Multiomics withAVITI24™
    Spatial Stage
    Speakers
    Rachel Piddock
    Rachel Piddock, Sr Field Application Scientist I - Element Biosciences
  3. Democratising The Analysis, Integration and Visualisation of Spatial, Single-Cell Transcriptomics and Proteomics Datasets Using Multi-Dimensional Viewer
    Spatial Stage
    Speakers
    Stephen Taylor
    Stephen Taylor,  Head of Integrative Computational Biology, Centre for Human Genetics -  University of Oxford
  4. Lunch Break
    Spatial Stage
  5. Insights From Molecular Mapping of Gastrointestinal Cancer Across Space and Time
    Spatial Stage
    Speakers
    Nigel Jamieson
    Nigel Jamieson, Professor of Surgery - University of Glasgow 
  6. Multi-omic Spatial Analysis Reveals Reshaping of Tumour-immune Dynamics at the Transition to Invasive Colorectal Cancer
    Spatial Stage
    Speakers
    Annie Baker
    Annie Baker, Senior Staff Scientist - Institute of Cancer Research
  7. Using GeoMx Spatial Transcriptomics to Understand How Microglia Interact With Plaques in Alzheimer's Disease; Insights From Human and Mouse Brains
    Spatial Stage
    Speakers
    Frances Edwards
    Frances Edwards, Professor of Neurodegeneration - University College London
  8. Networking Break
    Spatial Stage
  9. Unlocking Tissue Complexity Using Spatial Multi-Omics
    Spatial Stage
    Speakers
    Semiramis Popova
    Semiramis Popova, Associate Director - AstraZeneca
  10. Mapping the Key Factors Behind Skin Cancer Progression with Multimodal Spatial Profiling
    Spatial Stage
    Speakers
    Matthew Bottomley
    Matthew Bottomley, Lead for the CAMS Oxford Institute Spatial Profiling Hub - University of Oxford
  11. Spatial Proteogenomics of the Human Brain in Health and Disease
    Spatial Stage
    Speakers
    Olaf Ansorge
    Olaf Ansorge, Director, Academic Unit of Neuropathology, Nuffield Department of Clinical Neurosciences, University of Oxford - University of Oxford | Oxford University Hospitals NHS Trust
Cancer Diagnostics Stage
  1. Utilising Liquid Biopsy for Diagnosis and Surveillance of MRD in Head and Neck Cancer
    Cancer Diagnostics Stage
    Speakers
    Tim Aitman
    Tim Aitman, Director of the Centre for Genomic and Experimental Medicine - University of Edinburgh
  2. Translating Precision Oncology Profiling into Actionable Clinical Care : Bridging Diagnosis and Targeted Therapy Across Solid Tumors, Hematologic Malignancies and Liquid Biopsy
    Cancer Diagnostics Stage
    Speakers
    Hemaal Dhar
    Hemaal Dhar, Global Product Manager - NGS  - Genes2Me Pvt Ltd.
  3. Clinical Testing of Cancer Susceptibility Genes: A Public Health Perspective
    Cancer Diagnostics Stage
    Speakers
    Clare Turnbull
    Clare Turnbull, Professor of Cancer Genetics - Institute of Cancer Research London 
  4. Lunch Break
    Cancer Diagnostics Stage
  5. Clinical Applications of ctDNA Testing and Introducing New Indications
    Cancer Diagnostics Stage
    Speakers
    Matthew Krebs
    Matthew Krebs, Cancer Medical Lead - North West Genomic Laboratory Hub
  6. Liquid Biopsy or Tissue NGS testing in Oncology - Competing Options or a Complementary Strategy?
    Cancer Diagnostics Stage
    Speakers
    Gerald Martin 
    Gerald Martin , Commercial Applications Scientist - OncoDNA
    Petra Pekorna
    Petra Pekorna
  7. Precision Diagnostics in Pediatric Cancer Care
    Cancer Diagnostics Stage
    Speakers
    Bastiaan Tops
    Bastiaan Tops, Head of Diagnostic Laboratory - Princess Maxima Center for Pediatric Oncology
  8. Networking Break
    Cancer Diagnostics Stage
  9. The Future of Cancer Management: Genomics, Monitoring and Realities
    Cancer Diagnostics Stage
    Speakers
    Michael Hubank
    Michael Hubank, Head of Clinical Genomics - The Royal Marsden NHS Foundation Trust 
  10. PanSolid: Driving Diagnostic Innovation and Genomic Insights for Solid Tumours at NW GLH
    Cancer Diagnostics Stage
    Speakers
    Eleanor Baker
    Eleanor Baker, Clinical Scientist - Manchester University NHS Foundation Trust
    Helene Schlecht
    Helene Schlecht, Consultant Clinical Scientist, Northwest Genomic Laboratory Hub - Manchester University NHS Foundation Trust
  11. Clinical Implementation of Genomic Profiling to Advance the Diagnosis of Brain Tumours
    Cancer Diagnostics Stage
    Speakers
    Zita Reisz
    Zita Reisz, Consultant Neuropathologist & Lead Neuropathologist for Paediatric Neuro-Oncology - King’s College Hospital
Multi-Omics Stage
  1. Revealing Biological Mechanisms Through Multi-Omics Analyses
    Multi-Omics Stage
    Speakers
    Emma Laing
    Emma Laing, Senior Director of Computational Biology - GSK
  2. The Genome and Beyond: Advancing Drug Discovery and Development
    Multi-Omics Stage
    Speakers
    Dirk Paul
    Dirk Paul, Head of Development - Genomics
  3. The Expanding Role of Multi-omics in Early Drug Discovery
    Multi-Omics Stage
    Speakers
    Joanna Howson
    Joanna Howson, Scientific Vice President - Novo Nordisk
  4. Lunch Break
    Multi-Omics Stage
  5. Leveraging Multi Omics Platforms for Cancer Immunotherapy
    Multi-Omics Stage
    Speakers
    Samra Turajlic
    Samra Turajlic, Group Lead - The Francis Crick Institute
  6. Directly link genotype to phenotype. Discover a new era of multiomics within the same single-cells with Tapestri
    Multi-Omics Stage
    Speakers
    Dr. Robert Durruthy-Durruthy
    Dr. Robert Durruthy-Durruthy, VP, Global Support & Field Applications - Mission Bio
  7. Enabling Precision Medicine Using Multi-Omics, AI, and Systems Biology
    Multi-Omics Stage
    Speakers
    Adil Mardinoglu
    Adil Mardinoglu, Professor - King's College London
  8. Networking Break
    Multi-Omics Stage
  9. AI-Driven Integrative Analytics: A Case Study in Gastroenterology Cancers and IBD
    Multi-Omics Stage
    Speakers
    Animesh Acharjee
    Animesh Acharjee, Associate Professor of Integrative Analytics and AI - University of Birmingham
  10. Systems Vaccinology: Harnessing the Power of Multi-omics to Unravel the Mechanisms Underlying Immune Responses
    Multi-Omics Stage
    Speakers
    Daniel O'Connor
    Daniel O'Connor, Associate Professor, Head of Bioinformatics, Oxford Vaccine Group - University of Oxford
  11. From Stress to Strength: Evidence-Based Approaches to Enhance Mental Health
    Multi-Omics Stage
    Speakers
    Yasir Syed
    Yasir Syed, Senior Lecturer -  Cardiff University
Proteogenomics & Translational Omics Stage
  1. High-Throughput Proteomics Meets Population Science: The UK Biobank Approach & Future Directions
    Proteogenomics & Translational Omics Stage
    Speakers
    Martin Rutter
    Martin Rutter, Deputy Chief Scientist - UK Biobank
  2. Seeing Biology Clearly with Olink: Bringing the OH! to Prote-OH-mics!
    Proteogenomics & Translational Omics Stage
    Speakers
    David Harley
    David Harley, Strategic Director, Population Health EMEA - Olink, part of Thermo Fisher
    Fanny Taborsak-Lines
    Fanny Taborsak-Lines, Product Manager - Olink, part of Thermo Fisher
  3. Panel Discussion: How Is Translational Proteomics Shaping the Future of Drug Target Discovery?
    Proteogenomics & Translational Omics Stage
    Speakers
    Praveen Surendran
    Praveen Surendran, Associate Director, Human Genetics and Genomics - GSK
    Zhengming Chen
    Zhengming Chen, Richard Peto Professor of Epidemiology - Oxford Population Health
    Simon Lovestone
    Simon Lovestone, VP, Distinguished Fellow - Johnson & Johnson Innovative Medicine
  4. Lunch Break
    Proteogenomics & Translational Omics Stage
  5. Harnessing the power of proteomics in biobank studies to advance precision health
    Proteogenomics & Translational Omics Stage
    Speakers
    Zhengming Chen
    Zhengming Chen, Richard Peto Professor of Epidemiology - Oxford Population Health
  6. A Multi-Omics Approach to Uncovering Drug Resistance in HER2-Positive Cancer
    Proteogenomics & Translational Omics Stage
    Speakers
    Ateequllah Hayat
    Ateequllah Hayat, Lecturer in Drug Development - St George's School of Health and Medical Sciences
  7. Using Proteomics for Drug Discovery and Target ID for Major Depressive Disorders
    Proteogenomics & Translational Omics Stage
    Speakers
    Dame Carol Robinson
    Dame Carol Robinson, Director of the Kavli Institute for Nanoscience Discovery -  University of Oxford
  8. Networking Break
    Proteogenomics & Translational Omics Stage
  9. AI, Proteomics, and Advanced Analytics for Drug Development
    Proteogenomics & Translational Omics Stage
    Speakers
    Maria Dermit
    Maria Dermit, Senior Research Scientist - Novo Nordisk
  10. From immune repertoires to designed antibodies: AI models for nativeness, humanisation, and therapeutic design
    Proteogenomics & Translational Omics Stage
    Speakers
    Pietro Sormanni
    Pietro Sormanni, Associate Professor in Chemical Engineering - Imperial College London
  11. The Power to Predict and to Perceive: AI-Based Discovery in Proteomics Data
    Proteogenomics & Translational Omics Stage
    Speakers
    Lennart Martens
    Lennart Martens, Senior Full Professor of Systems Biology - Ghent University
AI In Drug Discovery Stage
  1. Scaling AI-Driven Discovery at Roche
    AI In Drug Discovery Stage
    Speakers
    Elif Ozkirimli
    Elif Ozkirimli, Head of Computational Science Products - Roche
  2. Better Inputs, Better Outputs: High-Dimensional Data for Tomorrow’s RNA Medicines
    AI In Drug Discovery Stage
    Speakers
    Wayne Doyle
    Wayne Doyle, Associate Director, Head of Scientific Strategy - Eclipsebio
  3. Advancing De Novo Drug Design Through Machine Learning
    AI In Drug Discovery Stage
    Speakers
    Friederike Biermann
    Friederike Biermann, Computational Scientist - Sanofi
  4. Lunch Break
    AI In Drug Discovery Stage
  5. Agentic AI in Molecular Dynamics Simulations: the Devil is in the Details
    AI In Drug Discovery Stage
    Speakers
    Guglielmo Iozzia
    Guglielmo Iozzia, Director, Data Sciences AI/ML - MSD 
  6. Cracking the Code of Biology: How Multi-Modal Foundation Models Will Transform Drug Discovery
    AI In Drug Discovery Stage
    Speakers
    Ketan Patel
    Ketan Patel, Head of Product - Bioptimus
  7. Accelerating Drug Discovery Through Genomics and AI
    AI In Drug Discovery Stage
    Speakers
    Zhihao Ding
    Zhihao Ding, Director and Global Head of Human Genetics; Head of Animal Health Genomics, - Boehringer Ingelheim
  8. Networking Break
    AI In Drug Discovery Stage
  9. Virtual Assays for Target Discovery: Bridging Human Biology, Functional Genomics, and Machine Learning.
    AI In Drug Discovery Stage
    Speakers
    Manu Verma
    Manu Verma, Senior Research Scientist in Functional Genomics - Novo Nordisk Research Centre Oxford
  10. Accelerating Cheminformatics and Bioinformatics with AI Powered Serverless HPC 
    AI In Drug Discovery Stage
    Speakers
    Fengbo Ren
    Fengbo Ren, Founder & CEO - Fovus
    Sunny Sharma
    Sunny Sharma, Founding PMM, HPC & AI - Fovus
  11. Applying Machine Learning on UK Biobank Biomarker Data Empowers Case-Control Discovery Yield
    AI In Drug Discovery Stage
    Speakers
    Manik Garg
    Manik Garg, Senior Data Scientist - AstraZeneca
Precision Medicine & Patient Stratification Stage
  1. Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)
    Precision Medicine & Patient Stratification Stage
    Speakers
    Sir Munir Pirmohamed
    Sir Munir Pirmohamed, Chair of Pharmaco
    -genetics - University of Liverpool 
  2. Prostate Cancer Polygenic Risk Scores in Clinic - Where are we and where do we go from here?
    Precision Medicine & Patient Stratification Stage
    Speakers
    Harry Green
    Harry Green,  Lecturer in Health Data Science - University of Exeter
  3. Pharmacogenomics and Healthcare
    Precision Medicine & Patient Stratification Stage
    Speakers
    Sir Mark Caulfield
    Sir Mark Caulfield, Professor of Clinical Pharmacology - Queen Mary University of London
  4. Lunch Break
    Precision Medicine & Patient Stratification Stage
  5. Pharmacogenomics Analyses: Biobanks, Study Design & Consortium Projects
    Precision Medicine & Patient Stratification Stage
    Speakers
    Helen Warren
    Helen Warren, Senior Lecturer in Statistical Genetics - Queen Mary University of London
  6. Pharmacogenomics Analysis at Scale for Safer and More Effective Patient Treatment
    Precision Medicine & Patient Stratification Stage
    Speakers
    Ellen McDonagh
    Ellen McDonagh, Translation Informatics Director - Open Targets
  7. Towards Population-Level Genomic Profiling - The Genomics England Adult Population Genomics Program
    Precision Medicine & Patient Stratification Stage
    Speakers
    Matt Brown
    Matt Brown, Chief Scientific Officer - Genomics England
  8. Networking Break
    Precision Medicine & Patient Stratification Stage
  9. Delivering Pharmacogenomic Services in Wales
    Precision Medicine & Patient Stratification Stage
    Speakers
    Sophie Harding
    Sophie Harding, Pharmacogenomics Lead - All Wales Medical Genomics Service
  10. Pharmacogenomics and Precision Medicine in the NHS in England: Embedding Genomics Informed Medicines Optimisation
    Precision Medicine & Patient Stratification Stage
    Speakers
    Vicky Chaplin
    Vicky Chaplin, Senior Clinical Lead, Genomics Unit - NHS England
  11. Mind the Implementation Gap: What If Every Older Adult Had Their Pharmacogenomic Profile on File?
    Precision Medicine & Patient Stratification Stage
    Speakers
    Sandosh Padmanabhan
    Sandosh Padmanabhan, Chair of Pharmacogenomics -  University of Glasgow
Bacteria, Bugs & Big Data Stage
  1. Changing the Surveillance Paradigm
    Bacteria, Bugs & Big Data Stage
    Speakers
    Charlene Rodrigues
    Charlene Rodrigues, Consultant in Genomics - UK Health Secuirty Agency
  2. From Patient to Population: Harnessing Pathogen Genomics Across the Welsh Healthcare System
    Bacteria, Bugs & Big Data Stage
    Speakers
    Tom Connor
    Tom Connor, Head of Public Health Genomics Programme -  Public Health Wales
  3. GAP-DC: An integrated One Health initiative for pathogen surveillance in the UK
    Bacteria, Bugs & Big Data Stage
    Speakers
    Yogesh Gupta
    Yogesh Gupta, Senior Scientist - Animal and Plant Health Agency (APHA)
  4. Lunch Break
    Bacteria, Bugs & Big Data Stage
  5. Genomics of Multi-Drug Resistance in Opportunistic Bacteria
    Bacteria, Bugs & Big Data Stage
    Speakers
    Willem Van Schaik
    Willem Van Schaik, Professor of Microbiology and Infection - University of Birmingham
  6. Genomic Surveillance of AMR: Practical Steps for Implementation
    Bacteria, Bugs & Big Data Stage
    Speakers
    David Aanensen
    David Aanensen, Director, Centre for Genomic Pathogen Surveillance - Pandemic Sciences Institute
  7. How Genomic Surveillance Can Inform Policies to Reduce the Burden of Antimicrobial Resistance in Low and Middle-Income Countries
    Bacteria, Bugs & Big Data Stage
    Speakers
    Esther van Kleef
    Esther van Kleef, Senior Research Associate - University of Oxford
  8. Networking Break
    Bacteria, Bugs & Big Data Stage
  9. Uncovering Long-Term Patterns in Pathogen Evolution with Big Data and Ancient DNA
    Bacteria, Bugs & Big Data Stage
    Speakers
    Lucy van Dorp
    Lucy van Dorp, Principal Research Fellow - University College London
  10. Genomics for Antimicrobial Resistance Surveillance to Support Infection Prevention and Control in Health
    Bacteria, Bugs & Big Data Stage
    Speakers
    Elita Jauneikaite
    Elita Jauneikaite, Assistant Professor in Microbiome and Bacterial Genomics - Imperial College London
  11. Population Genomics of Enteric Pathogens: From Ancient DNA to Modern Surveillance
    Bacteria, Bugs & Big Data Stage
    Speakers
    Nabil-Fareed Alikhan
    Nabil-Fareed Alikhan, Senior Bioinformatician, Centre for Genomic Pathogen Surveillance - University of Oxford
Epigenetics Stage
  1. Multiomic Single Cell WGS and Epigenomics to Track Drug Resistance Evolution in Cancer
    Epigenetics Stage
    Speakers
    Trevor Graham
    Trevor Graham, Director of the Centre for Evolution and Cancer - Institute of Cancer Research
  2. The 6-Base Genome Provides Synergistic Biomarkers for Earlier Detection of Colorectal Cancer
    Epigenetics Stage
    Speakers
    Sophie Kirschner
    Sophie Kirschner, Associate Director, Translational Medicine, Early Oncology - AstraZeneca
  3. Out of the Comfort Zone: Rethinking Approaches to study and contrast Breast Cancer Dormancy
    Epigenetics Stage
    Speakers
    Luca Magnani
    Luca Magnani, Professor  - The Institute of Cancer Research
  4. Insights into Neurodegeneration from DNA Methylation Studies on Human Brain Tissue
    Epigenetics Stage
    Speakers
    Conceição Bettencourt
    Conceição Bettencourt, Professorial Research Fellow - University College London
  5. Decoding Cell Division History in Humans with Evolving DNA Methylome
    Epigenetics Stage
    Speakers
    Zekey Zhang
    Zekey Zhang, Product Specialist - Beijing SeekGene BioSciences
    Zhigang Cai
    Zhigang Cai, Professor and Principle Investigator - Tianjin Medical University
  6. Single-cell approaches to dissect cell type-specific regulation at the CDKN2A/B locus
    Epigenetics Stage
    Speakers
    Elena Torlai Triglia
    Elena Torlai Triglia, Lecturer in Genetics, Genomics and Fundamental Cell Biology - Queen Mary University of London
  7. Networking Break
    Epigenetics Stage
  8. Epigenetic Technologies to Advance Cancer Detection and Cancer Biology
    Epigenetics Stage
    Speakers
    Chunxiao Song
    Chunxiao Song, Associate Professor at Ludwig Cancer Research - University of Oxford
  9. How The First Two Weeks After You Were Conceived Influences Your Lifelong Risk of Disease
    Epigenetics Stage
    Speakers
    Lori Kregar
    Lori Kregar, Postdoctoral Researcher - Wellcome Sanger Institute
  10. Explainable Artificial Intelligence Identifies Novel Regulatory Regions in the Human Genome and Their Epigenetic Code
    Epigenetics Stage
    Speakers
    Radu Zabet
    Radu Zabet, Reader of AI and Cancer Epigenetics - Queen Mary University of London
Live Lounge Stage
  1. Community Engagement in Genomics and Health Research. The Successes, the Challenges, Lessons Learnt and Next Steps
    Live Lounge Stage
    Speakers
    Manpreet Bains
    Manpreet Bains, Associate Professor, Faculty of Medicine & Health Sciences - University of Nottingham
    Rupinder Kaur Bajwa
    Rupinder Kaur Bajwa, Research Fellow - University of Nottingham
  2. The Chromosomes that NGS Forgot…
    Live Lounge Stage
    Speakers
    Allison Watson
    Allison Watson, Chief Executive Officer - Ring 20 Research & Support UK CIO
  3. How We’re Co-Creating The UK’s Largest Health Research Programme
    Live Lounge Stage
    Speakers
    Fiona Maleady-Crowe
    Fiona Maleady-Crowe, Chief Compliance and Integrity Officer - Our Future Health
  4. Integrating the Devyser CFTR NGS assay into routine Newborn Screening in Norway – efficient, flexible and scalable
    Live Lounge Stage
    Speakers
    Alexander D. Rowe
    Alexander D. Rowe, Head of Bioinformatics and Biobank, Norwegian Newborn Screening Program - Department of Newborn Screening, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Rikshospitalet, Norway
  5. Advancing Cancer Research: Genomic Profiling with QIAseq xHYB Trinity CGP
    Live Lounge Stage
    Speakers
    Pinar Uysal-Onganer
    Pinar Uysal-Onganer, Reader in Molecular Biology, Cancer Mechanisms and Biomarkers Research Group Leader - University of Westminster
  6. Streamlined NGS: Integrating the n6 icon96 for Faster, Cheaper Workflows
    Live Lounge Stage
    Speakers
    James Docker
    James Docker, NGS Lead and Multi-Omics Scientist - University of Oxford
  7. Why choose a DNBSEQ platform for your NGS workflow
    Live Lounge Stage
    Speakers
    Samantha Mendonsa
    Samantha Mendonsa, Product Manager - MGI Tech
  8. Keep Me Breathing: A Patient and Family Journey in Rare Disease
    Live Lounge Stage
    Speakers
    James Oakley
    James Oakley, Chairman - Keep Me Breathing Charity
  9. The Power of Listening: Patient Involvement Shaping Genomics in Wales
    Live Lounge Stage
    Speakers
    Alice Frenken
    Alice Frenken,  Project Manager - Genomics Partnership Wales
    Jennifer Griffiths
    Jennifer Griffiths, Sounding Board Member - Genomics Partnership Wales
  10. Networking break
    Live Lounge Stage
  11. Beyond Inclusion: Rebuilding Trust and Equity in the Genomic Era
    Live Lounge Stage
    Speakers
    Veline L’esperance
    Veline L’esperance, Senior Clinical Advisor - NHS Race and Health Observatory 
  12. Involving Community Organisations in Participant Recruitment For The Improving Black Health Outcomes (IBHO) BioResource
    Live Lounge Stage
    Speakers
    Anna Njie
    Anna Njie, Director - Go Africa Community Hub
    Ruth Yedu
    Ruth Yedu, Clinical Trials Assistant - NIHR Sheffield BRC BioResource
    Nathalie Kingston
    Nathalie Kingston, Director - NIHR BioResource
  13. Panel Discussion: Involving Children in Research: How the DNA, Children + Young People’s Health Resource (D-CYPHR) Programme Has Made Research a Family Activity
    Live Lounge Stage
    Speakers
    George Hudson
    George Hudson, Clinical Research Practitioner - NIHR Leicester BRC BioResource
    Hannah Stark
    Hannah Stark, Operations Lead - NIHR BioResource
    Keval Sachdev
    Keval Sachdev, Founder - Aikyam UK
Genomic Medicine Stage
  1. The Rise of Genomic Cellular Pathology in the NHS
    Genomic Medicine Stage
    Speakers
    Matthew Evans
    Matthew Evans, Consultant Cellular and Molecular Pathologist - University Hospitals Birmingham NHS Foundation 
  2. Mainstreaming Cancer Susceptibility Testing: Embedding Genetics Across Oncology Pathways
    Genomic Medicine Stage
    Speakers
    Angela George
    Angela George,  Clinical Director of Genomics and Consultant Medical Oncologist in Gynaecology - The Royal Marsden NHS Foundation Trust 
  3. Evolving Cancer Pathways: Using Genomics to Guide Precision Surgery and Patient Outcomes
    Genomic Medicine Stage
    Speakers
    Frank McDermott
    Frank McDermott, Acting Clinical Director - SW GMSA
  4. Lunch Break
    Genomic Medicine Stage
  5. Uncovering the Hidden Genome: New Insights into Neurodevelopmental Disorders
    Genomic Medicine Stage
    Speakers
    Adam Jackson
    Adam Jackson, Academic Clinical Fellow -  Manchester Centre for Genomic Medicine
  6. Making Genomics Matter: Delivering Timely, Actionable Cancer Testing in the NHS
    Genomic Medicine Stage
    Speakers
    Nirupa Murugaesu
    Nirupa Murugaesu,  Consultant in Molecular Oncology - Guy's and St Thomas' NHS Foundation Trust
  7. Raising the Bar in Rare Disease: Networks of Excellence, New Technologies and New Standards
    Genomic Medicine Stage
    Speakers
    Emma Baple
    Emma Baple, Professor of Genomic Medicine - University of Exeter
  8. Networking Break
    Genomic Medicine Stage
  9. How Do Digital, Data and AI Make Genomics Part of Everyday Care?
    Genomic Medicine Stage
    Speakers
    Videha Sharma
    Videha Sharma, Clinical Innovation Lead - University of Manchester
  10. Using Genomic and National Data to Support The Shift From Treatment to Prevention
    Genomic Medicine Stage
    Speakers
    Steven Hardy
    Steven Hardy, Head of Genomics and Rare DIsease - NHS England
  11. Moving Genomics Towards Primary Care
    Genomic Medicine Stage
    Speakers
    Joel Chatterjee
    Joel Chatterjee, General Practitioner - Royton & Crompton Family Practice
Advanced Therapies Stage
  1. Innovating Cell Therapies for Solid Tumours: From Discovery to Clinical Translation
    Advanced Therapies Stage
    Speakers
    Maike de la Roche
    Maike de la Roche, Group Leader -  Cancer Research UK
  2. Safe by Design: Unbiased Tools for CRISPR Safety in Cell and Gene Therapy
    Advanced Therapies Stage
    Speakers
    Giando Turchiano
    Giando Turchiano, Associate Director, Gene Editing Safety - AstraZeneca
  3. Panel Discussion: Designing for Success: Smarter Preclinical Strategies in Cell & Gene Therapy
    Advanced Therapies Stage
    Speakers
    Azadeh Kia
    Azadeh Kia, VP of Gene Therapy Research - Beacon Therapeutics 
    Trevor Smith
    Trevor Smith, VP of Preclinical R&D - Inovio Pharmaceuticals
    Diana Hernandez
    Diana Hernandez, Director of Immune and Advanced Therapies - Anthony Nolan 
  4. Lunch Break
    Advanced Therapies Stage
  5. Accelerating Access: Regulatory Support for Advanced Therapies in the UK
    Advanced Therapies Stage
    Speakers
    James Pound
    James Pound, Interim Executive Director of Innovation and Compliance - MHRA
  6. Panel Discussion: How Do We Design, Execute and Adapt Clinical Trials for One-Time or Personalised Advanced Therapies?
    Advanced Therapies Stage
    Speakers
    Laura Campbell
    Laura Campbell, Chief Medical Officer - Orchard Therapeutics
    Simon Jones
    Simon Jones, Consultant in Paediatric Inherited Metabolic Diseases - Manchester University NHS Foundation Trust
    James Pound
    James Pound, Interim Executive Director of Innovation and Compliance - MHRA
  7. Inside the Patient Experience of Advanced Therapies
    Advanced Therapies Stage
    Speakers
    Funmi Vanessa Ullam
    Funmi Vanessa Ullam, Parent of a Child with a Chronic Condition
    Chris Kessler
    Chris Kessler, Patient Voice - Parent of a Child with a Rare Disease
  8. Networking Break
    Advanced Therapies Stage
  9. Getting Commissioned ATMPs to Patients: Key Insights
    Advanced Therapies Stage
    Speakers
    Ben Doak
    Ben Doak, Head of Innovative Treatments - NHS England
  10. Building the Future of Advanced Therapies: Lessons from the ATTC Network
    Advanced Therapies Stage
    Speakers
    Emily Merrell
    Emily Merrell, Director of Advanced Therapy Treatment Centre Network - Cell and Gene Therapy, Catapult
  11. ATMP Engage: Perspectives from People who May Benefit from Advanced Therapies
    Advanced Therapies Stage
    Speakers
    Nick Meade
    Nick Meade, Chief Executive -  Genetic Alliance
    Laurence Woolard
    Laurence Woolard, Co-Chair, ATMP Engage - Cell and Gene Therapy Catapult
Women & Children's Health Stage
  1. Fetal Genomics: The Expanding Role of Prenatal Sequencing in Clinical Care
    Women & Children's Health Stage
    Speakers
    Dame Lyn Chitty
    Dame Lyn Chitty, Chair of Genetics and Fetal Medicine - University College London
  2. Precision Prediction and Prenatal Intervention for SCD: A Multimodal Biomarker Approach
    Women & Children's Health Stage
    Speakers
    Panicos Shangaris
    Panicos Shangaris,  Clinical Senior Lecturer and Consultant in Maternal and Fetal Medicine - King's College London
  3. The Implementation of Non-Invasive Prenatal Genomic Diagnostics in The NHS
    Women & Children's Health Stage
    Speakers
    Stephanie Allen
    Stephanie Allen, Consultant Clinical Scientist - Central and South Genomic Laboratory Hub, Birmingham Women’s Hospital
  4. Lunch Break
    Women & Children's Health Stage
  5. Newborn Genome Screening: Initial results of the Generation Study
    Women & Children's Health Stage
    Speakers
    David Bick
    David Bick, Principal Clinician, Newborn Genomes Programme - Genomics England
  6. Treating Metabolic Inherited Disorders
    Women & Children's Health Stage
    Speakers
    Simon Heales
    Simon Heales, Director of the Neurometabolic Unit - National Hospital, Queen Square 
  7. Panel Discussion: Evaluating the Impact of Newborn Sequencing
    Women & Children's Health Stage
    Speakers
    Melissa Hill
    Melissa Hill, Senior Social Scientist - Great Ormond Street Hospital
    James Buchanan
    James Buchanan, Senior Lecturer, Health Economics and Policy Research Unit - Queen Mary University of London
    Joachim Tan
    Joachim Tan, Senior Research Fellow in Health Data Science -  UCL Great Ormond Street Institute of Child Health
  8. Networking Break
    Women & Children's Health Stage
  9. The BabyDetect Project: Diagnosing Treatable Conditions Earlier
    Women & Children's Health Stage
    Speakers
    Francois Boemer
    Francois Boemer, Head of Human Genetics Department - University of Liege
  10. The Australian National Genomic Autopsy Study: A Summary of Results, Outcomes and Instructive Families from 413 Trios/Quads
    Women & Children's Health Stage
    Speakers
    Christopher Barnett
    Christopher Barnett, Head, Paediatric and Reproductive Genetics Unit - Women's and Children's Hospital Australia
  11. Genetic Predictors of Diabetes in Pregnancy
    Women & Children's Health Stage
    Speakers
    Julia Zollner
    Julia Zollner, NIHR Clinical Lecturer - University College London
AI In Healthcare Transformation Stage
  1. Harnessing AI to Improve Cancer Diagnostics
    AI In Healthcare Transformation Stage
    Speakers
    Sowmiya Moorthie
    Sowmiya Moorthie, Senior Strategic Evidence Manager - Cancer Research UK 
  2. Panel Discussion: Genomic AI: Building Intelligence for National Health Systems with Global Standards
    AI In Healthcare Transformation Stage
    Speakers
    Timon Heide
    Timon Heide, Staff Bioinformatics Scientist - Illumina
    Augusto Rendon
    Augusto Rendon, Chief Bioinformatician - Genomics England
    Sarah Ennis
    Sarah Ennis, Research Director - NHS
    Sasha Siegel
    Sasha Siegel, Chief Product Officer - GA4GH
  3. AI Hesitancy in Healthcare: Understanding Disengagement with AI-Powered Tools
    AI In Healthcare Transformation Stage
    Speakers
    Tom Nadarzynski
    Tom Nadarzynski, Research Lead,  Solent NHS Trust and Senior Lecturer - University of Westminster
  4. Lunch Break
    AI In Healthcare Transformation Stage
  5. AI Integration Across Health and Life Sciences: Oncology, Trauma, and Oral Health
    AI In Healthcare Transformation Stage
    Speakers
    Tuan Pham
    Tuan Pham, Professor of AI in Imaging, Diagnostics, and Trauma - Queen Mary University of London
  6. Mind the Gap: AI and Barriers to Implementation in Imaging-Based Screening
    AI In Healthcare Transformation Stage
    Speakers
    Adnan Taib
    Adnan Taib, Clinical Research Fellow - University of Nottingham
  7. Multimodal AI for Imaging–Omics Data Fusion with Interpretable Insights
    AI In Healthcare Transformation Stage
    Speakers
    Greg Slabaugh
    Greg Slabaugh, Director of the Digital Environment Research Institute and Professor of Computer Vision and AI - Queen Mary University of London
  8. Networking Break
    AI In Healthcare Transformation Stage
  9. Deep Data for Translational Research: The Thames Valley and Surrey Secure Data Environment
    AI In Healthcare Transformation Stage
    Speakers
    Kerrie Woods
    Kerrie Woods,  Director R&D Clinical Informatics - Oxford University Hospitals 
    Jim Davies
    Jim Davies, Chief Technology Officer - Thames Valley & Surrey NHS Secure Data Environment
  10. AI For Diagnosis in Primary Care: Regulatable AI Models and Virtual Doctors
    AI In Healthcare Transformation Stage
    Speakers
    Brendan Delaney
    Brendan Delaney, Chair in Medical Informatics and Decision Making - Imperial College London
  11. More details to be announced shortly
    AI In Healthcare Transformation Stage
Workshop Room - Gallery Room SG10
  1. Workshop: Life Sciences CV Masterclass
    Workshop Room - Gallery Room SG10
    Speakers
    Renee Lee
    Renee Lee, Associate Professor in Biological Sciences - University of Reading
    Phil Lang
    Phil Lang, Placements Coordinator - University of York
  2. Workshop: Developing Your Career with Personal Branding
    Workshop Room - Gallery Room SG10
    Speakers
    Ann Brine
    Ann Brine, Head of Marketing Services - Promega
  3. Workshop: Career Taster - Clinical Scientist in Genomics
    Workshop Room - Gallery Room SG10
    Speakers
    Nick Hickson
    Nick Hickson, Scientific Education and Training Lead - South East Genomic Laboratory Hub / Synnovis
    Layla Afkhami
    Layla Afkhami,  Scientific Training Officer (Practice Educator) -  Synnovis, Guy’s Hospital 
  4. Networking Break
    Workshop Room - Gallery Room SG10
  5. Workshop: Single Cell Data Analysis With Python
    Workshop Room - Gallery Room SG10
    Speakers
    Georgia Whitton
    Georgia Whitton, Senior Bioinformatician - The Francis Crick Institute
    James Campbell
    James Campbell, Bioinformatics Training Developer - The Francis Crick Institute
    Lina Gerontogianni
    Lina Gerontogianni, Senior Statistician - Francis Crick Institute
Genome Dome
  1. Roundtable Discussion: Closing The Digital Skills Gap in Life Sciences
    Genome Dome
    Speakers
    Helen Jourdain-Dawe
    Helen Jourdain-Dawe, Head of Bioscience and Chemistry - Northeastern University London
    Mark Kristiansen
    Mark Kristiansen, Head of UCL Genomics and Associate Professor (Education) - University College London
    Georgia Whitton
    Georgia Whitton, Senior Bioinformatician - The Francis Crick Institute
    Isabelle Jourdain-Dawe
    Isabelle Jourdain-Dawe, Head of Discovery - BindBridge
  2. Lunch Break
    Genome Dome
  3. Roundtable Discussion: Catalysing Discovery at The Intersection of Genomics, Humanities, Social Sciences and Bioethics
    Genome Dome
    Speakers
    Paul Meller
    Paul Meller, Research Lead, Discovery Research - Wellcome Trust
    Joy Zhang
    Joy Zhang, Professor of Sociology - University of Kent
    Leigh Jackson
    Leigh Jackson, Project Researcher - University of Exeter
    Veline L’esperance
    Veline L’esperance, Senior Clinical Advisor - NHS Race and Health Observatory 
    Harry Farmer
    Harry Farmer, Senior Researcher - Ada Lovelace Institute
    Peter Kilroy
    Peter Kilroy, Senior Research Manager - Wellcome Trust
    Helena Wells
    Helena Wells, Research Manager - Major Initiatives - Wellcome Trust
  4. Networking Break
    Genome Dome
  5. Exploring The Latest Genomes and Gene annotations In The New Ensembl Data Platform
    Genome Dome
    Speakers
    Jorge Batista da Rocha
    Jorge Batista da Rocha, Outreach Project Leader - Ensembl
  1. Lunch Break
  2. Networking Break
Main Stage
  1. Keynote Address
    Main Stage
    Speakers
    Minister Zubir Ahmed
    Minister Zubir Ahmed, Parliamentary Under-Secretary of State for Health Innovation and Safety - Department of Health and Social Care 
  2. UK Biobank: Crowdsourcing Discovery Science
    Main Stage
    Speakers
    Sir Rory Collins
    Sir Rory Collins, Chief Executive - UK Biobank
  3. Building a High Quality Multiomic Dataset in Rare Disease
    Main Stage
    Speakers
    Greg Elgar
    Greg Elgar, Director of Sequencing R&D - Genomics England
    Anthony Rogers
    Anthony Rogers, Associate Director, Scientific Research - Illumina
  4. Keynote Address
    Main Stage
    Speakers
    Lord Patrick Vallance
    Lord Patrick Vallance, Minister of State - Science, Research and Innovation
  5. The Future of Clinical Trials in The UK: Aligning National Assets With Industry Needs
    Main Stage
    Speakers
    Raghib Ali
    Raghib Ali, Chief Executive - Our Future Health
  6. Panel Discussion: Genomics, Strategy and the Next Decade of UK Life Sciences
    Main Stage
    Speakers
    Dame Anna Dominiczak
    Dame Anna Dominiczak, Chief Scientific Adviser (Health) - Scottish Government
    Isabel Oliver
    Isabel Oliver, Chief Medical Officer - Welsh Government
    Lawrence Tallon
    Lawrence Tallon, Chief Executive - MHRA
    Steve Bates
    Steve Bates, Executive Chair - Office for Life Sciences
    Richard Torbett
    Richard Torbett, Chief Executive  - Association of the British Pharmaceutical Industry (ABPI) 
    Beth Thompson
    Beth Thompson, Director of Policy & Partnerships - Wellcome Trust
    Raghib Ali
    Raghib Ali, Chief Executive - Our Future Health
  7. Networking Break
    Main Stage
  8. Tracking Inherited Cancer Risk: How the NICPR Enables Early Detection and Improved Care
    Main Stage
    Speakers
    Helen Hanson
    Helen Hanson, Consultant in Clinical Genetics - Royal Devon University Healthcare NHS Foundation Trust
  9. Connecting People, Shaping Practice: Developing the UK Genomic Network
    Main Stage
    Speakers
    Sarah Cunningham-Burley
    Sarah Cunningham-Burley, Chair of the Nuffield Council on Bioethics and Professor of Medical and Family Sociology  - University of Edinburgh
  10. Lunch Break
    Main Stage
  11. Pinprick Blood Test that Could Detect Disease 10 Years Before Symptoms
    Main Stage
    Speakers
    Julian Mutz
    Julian Mutz, King’s Prize Research Fellow - King's College London
  12. Cracking Nature’s Code: How the Naked Mole-Rat’s DNA May Unlock Healthy Ageing
    Main Stage
    Speakers
    Gabriel Balmus
    Gabriel Balmus, Group Leader - UK Dementia Research Institute, University of Cambridge
  13. From Rare Disease to Breakthrough: What First-In-Human Gene Therapy for Hunter Syndrome Means for Advanced Therapies
    Main Stage
    Speakers
    Simon Jones
    Simon Jones, Consultant in Paediatric Inherited Metabolic Diseases - Manchester University NHS Foundation Trust
  14. Panel Discussion: Beyond Sick Care: Building a Prevention-Driven Health System in the UK?
    Main Stage
    Speakers
    Cosima Gretton
    Cosima Gretton, Chief Product Officer -  Our Future Health
    Vageesh Jain
    Vageesh Jain, Consultant in Public Health Medicine and Senior Lecturer - NHS South West London
    Shireen Kassam
    Shireen Kassam, Consultant Haematologist, Lifestyle Medicine Physician - King’s College Hospital
    Thomas Beaney
    Thomas Beaney,  Clinical Research Fellow and GP - The George Institute for Global Health 
  15. Networking Break
    Main Stage
  16. A Fireside Chat with Sir Stephen Fry
    Main Stage
    Speakers
    Sir Stephen Fry
    Sir Stephen Fry, Actor, Author and Comedian - Independent
    Vivienne Parry
    Vivienne Parry, Writer, broadcaster, facilitator - Independent
Biodata Stage
  1. Why Data Matters: Enabling Large-Scale Population Health Research in The UK in The “Big Data” Era.
    Biodata Stage
    Speakers
    Cathie Sudlow
    Cathie Sudlow,  Director of the Usher Institute - University of Edinburgh
  2. Delivering National Clinical Genomic Services on AWS: The All Wales Experience
    Biodata Stage
    Speakers
    Joseph Halstead
    Joseph Halstead, Lead Bioinformatician - All Wales Medical Genomics Service
    Michael Mueller
    Michael Mueller, Senior Solutions Architect - AWS
  3. OpenSAFELY: How We Delivered Secure Access to all 58 Million NHS GP Records in England
    Biodata Stage
    Speakers
    Ben Goldacre
    Ben Goldacre, Director of Bennett Institute for Applied Data Science - University of Oxford
  4. Lunch Break
    Biodata Stage
  5. Delivering Insight at Scale Using FAIR Data Principles
    Biodata Stage
    Speakers
    Nathalie Conte
    Nathalie Conte, R&D Lead for FAIR data integration - AstraZeneca
  6. Harnessing Data & AI for the future of Life Sciences
    Biodata Stage
    Speakers
    Thomas Harrer
    Thomas Harrer, CTO Storage EMEA, Distinguished Engineer - IBM
  7. Networking Break
    Biodata Stage
  8. The GA4GH Beacon Protocol - Federating Data Discovery and Sharing in Biomedical Genomics
    Biodata Stage
    Speakers
    Michael Baudis
    Michael Baudis, Professor -  University of Zurich 
  9. Panel Discussion: Building Trust: Ensuring Accountability and Quality in Biodata Systems
    Biodata Stage
    Speakers
    Rohini Mathur
    Rohini Mathur, Professor and Chair of Health Data Science - Queen Mary University of London
    Andy Yates
    Andy Yates, Team Leader, Genomics Technology Infrastructure - EMBL-EBI 
    Cassie Smith
    Cassie Smith, Director for Legal Trust and Ethics - HDRUK
    Arcadi Navarro Cuartiellas
    Arcadi Navarro Cuartiellas, EGA Director - Center for Genomic Regulation
  10. Healthcare Data Acquisition: A National Consent Mechanism
    Biodata Stage
    Speakers
    Rhys Vaughan
    Rhys Vaughan, Genomics Consent Manager - Wales Gene Park
Single-Cell Stage
  1. Population-Scale Single-Cell Genomics Informs Diagnosis and Treatment of Human Diseases
    Single-Cell Stage
    Speakers
    Nicole Soranzo
    Nicole Soranzo, Head of Genomics Research Centre - Population & Medical Genomics - Human Technopole
  2. Ushering in a New Era of Biological Discovery With Scaled Up Single Cell Sequencing
    Single-Cell Stage
    Speakers
    Mike Day
    Mike Day, District Sales Manager - Parse Biosciences
  3. Single-Cell Phenotyping and DNA Profiling to Deconvolute Forensic Biological Mixtures Originating From Multiple Contributors
    Single-Cell Stage
    Speakers
    Iain Macaulay
    Iain Macaulay, Group Leader - Earlham Institute
  4. Lunch Break
    Single-Cell Stage
  5. Decoding Blood using Single-Cell Genomics: how embryos teach us to make stem cells
    Single-Cell Stage
    Speakers
    Gi Fay Mok
    Gi Fay Mok, Lecturer in Biomedicine & Group Leader at the BioMedical Research Centre - University of East Anglia
  6. scExCpGm: a new single-cell sequencing platform for cocurrent profiling gene expression and genomic CpG methylation atlas in biology and disease research
    Single-Cell Stage
    Speakers
    Shouwen Wang
    Shouwen Wang, Assistant Professor - Westlake University
  7. Single-Cell and AI/ML to Understand Human Development and Disease
    Single-Cell Stage
    Speakers
    Muzlifah Haniffa
    Muzlifah Haniffa, Head of Cellular Genomics - Wellcome Sanger Institute 
  8. Networking Break
    Single-Cell Stage
  9. Panel Discussion: Bridging the Gap: Integrating Single-Cell and Spatial Transcriptomics for Deeper Biological Insights
    Single-Cell Stage
    Speakers
    Meryam Beniazza
    Meryam Beniazza, Single Cell Multi Omics Specialist -  University of Edinburgh
    Ralf Jungmann
    Ralf Jungmann, Professor of Biochemistry and Biophysics -  Max Plank Institute of Biochemistry 
    Daria Gavriouchkina
    Daria Gavriouchkina, Single Cell and Spatial Transcriptomics Platform Manager - UKDRI Imperial College London
    Michela Noseda
    Michela Noseda, Reader in Cardiovascular Science, National Heart & Lung Institute - Faculty of Medicine - Imperial College London
  10. Stage Closed
    Single-Cell Stage
Spatial Stage
  1. GBM-Space: Dissecting the Cellular Circuits of Glioblastoma Using Single Cell and Spatial Genomics
    Spatial Stage
    Speakers
    Omer Bayraktar
    Omer Bayraktar, Group Leader - Wellcome Trust Sanger Institute
  2. Exploring spatial dependencies in the tissue and 3D model proteomes and addressing data scarcity in proteomics
    Spatial Stage
    Speakers
    Roman Fischer
    Roman Fischer, Associate Professor and Head of Discovery Proteomics Facility - University of Oxford
  3. Exploring Multiscale Single-Cell Signalling via SIGNAL-seq PTM Profiling and Biophysics-Aware Spatial Transcriptomics
    Spatial Stage
    Speakers
    James Opzoomer
    James Opzoomer, Senior Scientist, Innovation Lab - Relation Therapeutics
  4. Lunch Break
    Spatial Stage
  5. From Archives to Insights: Unraveling placental disorders with Single-Cell and Spatial Transcriptomics
    Spatial Stage
    Speakers
    Yara Sanchez-Corrales
    Yara Sanchez-Corrales, Computational Research Fellow at the Institute of Child Health - University College London
  6. Clinical impact of spatial inter-tumoural heterogeneity in Ovarian High Grade Serous Carcinoma (HGSC)
    Spatial Stage
    Speakers
    Paula Cunnea
    Paula Cunnea, Advanced Research Fellow - Imperial College London
  7. Theatre Closed
    Spatial Stage
Cancer Diagnostics Stage
  1. Liquid Biopsy from Research to Practice in Lung Cancer
    Cancer Diagnostics Stage
    Speakers
    Alastair Greystoke
    Alastair Greystoke, Clinical Senior Lecturer and Honorary Consultant - Newcastle University
  2. Liquid Biopsy in Practice: Current Applications and Future Directions
    Cancer Diagnostics Stage
    Speakers
    Persephone du Parcq
    Persephone du Parcq, Lead Clinical/Translational Scientist - Synnovis, UK
  3. The Role of Liquid Biopsy in The NHS Cancer Diagnostic Pathways
    Cancer Diagnostics Stage
    Speakers
    Sian Morgan
    Sian Morgan, All Wales Medical Genomics Service Laboratory Director - NHS Wales
  4. Lunch Break
    Cancer Diagnostics Stage
  5. Rethinking Early Cancer Detection: Lessons from Over a Decade of Liquid Biopsy Development
    Cancer Diagnostics Stage
    Speakers
    Nitzan Rosenfeld
    Nitzan Rosenfeld, Director and Professor of Applied Cancer Research - Queen Mary University of London
  6. Molecular Residual Disease Monitoring in Breast Cancer
    Cancer Diagnostics Stage
    Speakers
    Isaac Garcia-Murillas
    Isaac Garcia-Murillas, Senior Staff Scientist - Institute of Cancer Research
  7. The SMPaeds2 Study: The Power of ctDNA in Paediatric Cancer
    Cancer Diagnostics Stage
    Speakers
    Sally George
    Sally George, Paediatric Oncologist and Group Leader - The Institute of Cancer Research
  8. Networking Break
    Cancer Diagnostics Stage
  9. The AI Infection Point for Genomics - the UK Cancer AI Scientist & Supercomputing Project
    Cancer Diagnostics Stage
    Speakers
    Lennard Lee
    Lennard Lee, Chief Medical Officer - Ellison Institute of Technology
    Gareth Bloomfield
    Gareth Bloomfield, Senior Scientist - Cancer AI Scientist Project
  10. MCED - DNA Methylation-Based Liquid Biopsy for Early Detection of HPV-Related Cancers
    Cancer Diagnostics Stage
    Speakers
    Belinda Nedjai
    Belinda Nedjai, Director of the Molecular Epidemiology Laboratory - Queen Mary University of London
Multi-Omics Stage
  1. Knowledge-Based Machine Learning to Extract Disease Mechanisms From Spatial Multi-Omics Data
    Multi-Omics Stage
    Speakers
    Julio Saez-Rodriguez
    Julio Saez-Rodriguez, Head of Research - EMBL-EBI 
  2. Pan-cancer Drivers of Metastasis
    Multi-Omics Stage
    Speakers
    Vijay Tiwari
    Vijay Tiwari, Professor and Head of Genome Biology, Institute for Molecular Medicine (IMM) - University of Southern Denmark
  3. Multi-Omics Approaches for Elucidating Disease Mechanisms and Enhancing Risk Prediction
    Multi-Omics Stage
    Speakers
    Michael Inouye
    Michael Inouye, Professor - University of Cambridge
  4. Lunch Break
    Multi-Omics Stage
  5. Embedding Multi-Omics within the NHS: Challenges and Opportunities
    Multi-Omics Stage
    Speakers
    Emma Braybrook
    Emma Braybrook, Lead Scientist, Multi-Omics Laboratory - University Hospitals Coventry and Warwickshire
  6. SPACE: A Centre Of Excellence To democratize & Scale Up Spatial omics
    Multi-Omics Stage
    Speakers
    Dario Bressan
    Dario Bressan, Head of the Spatial Profiling and Annotation Centre of Excellence (SPACE) - Cancer Research Cambridge Institute
  7. AI/ML Powered Multi Omics Data Integration for Motor Neuron Disease
    Multi-Omics Stage
    Speakers
    Alfredo Iacoangeli
    Alfredo Iacoangeli, Professor of Bioinformatics and Artificial Intelligence for Genomic Medicine - King's College London
  8. Networking Break
    Multi-Omics Stage
  9. NIHR Bioresource: Advancing Rare Disease research with Omics technologies.
    Multi-Omics Stage
    Speakers
    Kathy Stirrups
    Kathy Stirrups, Head of Samples - NIHR BioResource
  10. High-Resolution Biology: Multi-Dimensional Insights from Spatial Multi-Omics
    Multi-Omics Stage
    Speakers
    Paolo Piazza
    Paolo Piazza, Head of the Multi Omics Research Facility -  University of Oxford
Proteogenomics & Translational Omics Stage
  1. From Rare to Common: Insights Into Human Diseases From Proteogenomic Studies
    Proteogenomics & Translational Omics Stage
    Speakers
    Mine Koprulu
    Mine Koprulu, Postdoctoral Researcher - Precision Healthcare University Research Institute (PHURI)
  2. The Potential of Proteomics in Cardiovascular Risk Prediction
    Proteogenomics & Translational Omics Stage
    Speakers
    Frederick Ho
    Frederick Ho, Senior Lecturer - University of Glasgow 
  3. Proxy-Ubiquitomics for Drug Discovery in the Ubiquitin System
    Proteogenomics & Translational Omics Stage
    Speakers
    Benedikt Kessler
    Benedikt Kessler, Professor of Biochemistry and Mass Spectrometry -  University of Oxford
  4. Lunch Break
    Proteogenomics & Translational Omics Stage
  5. Cracking the Mass Spectrometry Code: Artificial intelligence for de novo peptide sequencing
    Proteogenomics & Translational Omics Stage
    Speakers
    Wout Bittremieux
    Wout Bittremieux, Assistant Research Professor - University of Antwerp
  6. Proteogenomic Landscape of Type 2 Diabetes in African Ancestry Individuals
    Proteogenomics & Translational Omics Stage
    Speakers
    Opeyemi Soremkun
    Opeyemi Soremkun, Lecturer - University of Exeter
  7. Role of Phosphoproteomics in The Development of Personalised Oncology
    Proteogenomics & Translational Omics Stage
    Speakers
    Pedro Rodriguez Cutillas
    Pedro Rodriguez Cutillas,  Professor of Cell Signalling and Proteomics - Barts Cancer Institute
  8. Networking Break
    Proteogenomics & Translational Omics Stage
  9. Panel Discussion: Moving Beyond Genomics through the Integration of Proteomics and Multi-Omics Data
    Proteogenomics & Translational Omics Stage
    Speakers
    Clive D'Santos
    Clive D'Santos, Head of Proteomics - Cancer Research UK 
    Becky Carlyle
    Becky Carlyle, Group Leader - Oxford-GSK
    Ioanna Tzoulaki
    Ioanna Tzoulaki, Professor of Chronic Disease Epidemiology in the School of Public Health - Imperial College London
AI In Drug Discovery Stage
  1. Deploying AI for Early Phase Oncology Trials
    AI In Drug Discovery Stage
    Speakers
    Karen Sayal
    Karen Sayal, Consultant Clinical Oncologist, the Translational AI Innovation Lead - University College London Hospitals NHS Foundation Trust
  2. Turning Fragmented Evidence into Informed Target Selection with DISGENET
    AI In Drug Discovery Stage
    Speakers
    Janet Piñero
    Janet Piñero, Co-Founder and Head of Bioinformatics - MedBioinformatics
  3. Novel Deep Learning Architectures for Patient Cohort Data
    AI In Drug Discovery Stage
    Speakers
    Marie Lisandra Zepeda Mendoza
    Marie Lisandra Zepeda Mendoza,  Specialist - Novo Nordisk
  4. Lunch Break
    AI In Drug Discovery Stage
  5. Deep Phenotyping via EHR Transformers: Leveraging Biomarker and Imaging Data for Comprehensive Subtype Characterization
    AI In Drug Discovery Stage
    Speakers
    Hanati Tuoken
    Hanati Tuoken,  Principal Scientist (ML & AI) - Boehringer Ingelheim
  6. Machine learning combined with 3D genomics identify drug targets with boosted clinical success chances
    AI In Drug Discovery Stage
    Speakers
    Basel Abu-Jamous
    Basel Abu-Jamous, Director of Computational Biology - Nucleome Therapeutics
  7. AI-Powered Drug and Biomarker Discovery Using Multi-Modal Image Data
    AI In Drug Discovery Stage
    Speakers
    Heba Sailem
    Heba Sailem,  Head of Biomedical AI - King's College London
  8. Networking Break
    AI In Drug Discovery Stage
  9. Stage Closed
    AI In Drug Discovery Stage
Precision Medicine & Patient Stratification Stage
  1. Precision Cardiology : The Art of Risk Stratification in The Real World
    Precision Medicine & Patient Stratification Stage
    Speakers
    Rameen Shakur
    Rameen Shakur, Professor of Genomics and Cardiovascular Medicine - University of Brighton
  2. Unlocking Precision Medicine at Scale: From Genomic Interactions to Pharmacogenomics
    Precision Medicine & Patient Stratification Stage
    Speakers
    Natalie Twine
    Natalie Twine, Senior Research Scientist - CSIRO 
  3. Rare Disease Gene Association Discovery in The 100,000 Genomes Project
    Precision Medicine & Patient Stratification Stage
    Speakers
    Hannah Mitchison
    Hannah Mitchison, Professor of Molecular Medicine - University College London
  4. Lunch Break
    Precision Medicine & Patient Stratification Stage
  5. Integrating Genetics Across the Drug R&D Pipeline
    Precision Medicine & Patient Stratification Stage
    Speakers
    James Staley
    James Staley, Director of Computational Genetics - UCB
  6. From FFPE to Insight: 10x FLEX scRNA‑seq for MoA, Resistance, and Patient Stratification
    Precision Medicine & Patient Stratification Stage
    Speakers
    Silvia-Elena Glont
    Silvia-Elena Glont, Senior Scientist, Translational Genomics - AstraZeneca
  7. Topological Analysis of Pathway Activation Reveals Molecular Phenotypes in IBD for Precision Stratification and Targeted Therapy
    Precision Medicine & Patient Stratification Stage
    Speakers
    Paul Skipp
    Paul Skipp, Professor of Proteomics and Co-Founder of TopMD -  University of Southampton 
  8. Networking Break
    Precision Medicine & Patient Stratification Stage
  9. Your DNA, Your Warning: Using Genomes to Outpace Heart Disease
    Precision Medicine & Patient Stratification Stage
    Speakers
    Marta Futema
    Marta Futema, Lecturer in Cardiovascular Science - City St. George's, University London
  10. Panel Discussion: Integration of PRS Alongside Multi-Modal for Stratification and Risk Prediction
    Precision Medicine & Patient Stratification Stage
    Speakers
    Saskia Sanderson
    Saskia Sanderson, Senior Research Fellow, Biostatistics & Health Informatics - King's College London
    Zaed Hamady
    Zaed Hamady, Senior Consultant and Clinician -  University Hospital Southampton NHS Foundation Trust
    Luis Da Rocha Lopes
    Luis Da Rocha Lopes, Associate Professor, Institute of Cardiovascular Science - University College London
Bacteria, Bugs & Big Data Stage
  1. Microbial–Immune Crosstalk During Infant Weaning: Long-term Determinants of Health, Autoimmune Risk, and Strategies for Prevention
    Bacteria, Bugs & Big Data Stage
    Speakers
    Marcin Pekalski
    Marcin Pekalski, Host and Microbe Investigator - MIM National Research Institute, Warsaw, & Centre for Human Genetics, University of Oxford
  2. Oralisation, Dysbiosis and Defence: Host–Microbiome Dialogues Across Epithelial Surfaces
    Bacteria, Bugs & Big Data Stage
    Speakers
    David Moyes
    David Moyes, Group Lead, Functional Microbiome Group - King's College London
  3. Investigating Host-Microbiome Interactions with Computational and Organoid Based Approaches
    Bacteria, Bugs & Big Data Stage
    Speakers
    Tamas Korcsmaros
    Tamas Korcsmaros, Associate Professor - Imperial College London
  4. Lunch Break
    Bacteria, Bugs & Big Data Stage
  5. From Gut to Lung: Using Metagenomics to Understand How Early Gut Colonisers Shape the Risk of Severe Respiratory Infections in Childhood
    Bacteria, Bugs & Big Data Stage
    Speakers
    Nigel Field
    Nigel Field, Professor of Infectious Disease & Epidemiology - University College London
  6. Respiratory Microbiome Dysbiosis and Temporal Dynamics in Individuals with Asthma
    Bacteria, Bugs & Big Data Stage
    Speakers
    Spyridon Megremis
    Spyridon Megremis, Lecturer in Microbial and Phage Biology - University of Leicester
  7. Malnourished Microbes: How the Gut Microbiome Affects Growth in Children at Risk of Undernutrition
    Bacteria, Bugs & Big Data Stage
    Speakers
    Ruairi Robertson
    Ruairi Robertson, Lecturer in Microbiome Science - Queen Mary University of London
  8. Networking Break
    Bacteria, Bugs & Big Data Stage
  9. Healthy Microbiome—Moving Towards Functional Interpretation
    Bacteria, Bugs & Big Data Stage
    Speakers
    Kinga Zielinska
    Kinga Zielinska, Bioinformatician -  Jagiellonian University
    Pawel Labaj
    Pawel Labaj,  Bioinformatics Group Leader - Jagiellonian University
  10. Stage Closed
    Bacteria, Bugs & Big Data Stage
Epigenetics Stage
  1. Enhancer heterogeneity in leukaemia drives patient specific transcriptional profiles
    Epigenetics Stage
    Speakers
    Thomas Milne
    Thomas Milne, Professor of Haematology - University of Oxford
  2. Rapid Brain Tumour Classification From Epigenomic Data
    Epigenetics Stage
    Speakers
    Alena van Bommel
    Alena van Bommel, Associate Professor for Neuroepigenetics and Data Science at the Biomedical Center - Ludwig-Maximilians-Universität Munich
  3. Unpicking Alzheimer's disease: Understanding Links Between Mental Health, Genetics, and Neurodegenerative Disease
    Epigenetics Stage
    Speakers
    Donald Lyall
    Donald Lyall, Senior Lecturer - University of Glasgow 
  4. Decoding Epigenetic Barcodes in Blood for Early Detection of Neurodegeneration
    Epigenetics Stage
    Speakers
    Emma Dempster
    Emma Dempster, Senior Lecturer - Exeter University 
  5. Epigenetic Signatures of Mental Health and Wellbeing
    Epigenetics Stage
    Speakers
    Chloe Wong
    Chloe Wong, Reader in Epigenomics - King's College London
  6. Epigenetic and Genomic Risk of Alzheimer’s Disease
    Epigenetics Stage
    Speakers
    Alexi Nott
    Alexi Nott,  Group Leader  - UKDRI Imperial College London
  7. Networking Break
    Epigenetics Stage
  8. Theatre Closed
    Epigenetics Stage
Live Lounge Stage
  1. RNA Sequencing of Giant Cell Arteritis Lesions Uncovers the Molecular Landscape of Early Treatment Response and Reveals Predictors of Refractory and Relapsing Disease
    Live Lounge Stage
    Speakers
    Michal Zulcinski
    Michal Zulcinski, Postdoctoral Researcher - University of Leeds
  2. Multimodal Single-Cell Profiling in Thyroid Eye Disease
    Live Lounge Stage
    Speakers
    Anne Nguyen
    Anne Nguyen, PhD Student - University of Oxford
  3. Genetic Research on Individual Differences on Cognitive Abilities
    Live Lounge Stage
    Speakers
    Robert Plomin
    Robert Plomin, Professor of Behavioural Genetics - King's College London
  4. Decoding Patient Experiences: Communicating the Human Side of Genomic Medicine
    Live Lounge Stage
    Speakers
    Susie Weller
    Susie Weller, Research Fellow - Centre for Personalised Medicine
    Kate Lyle
    Kate Lyle, Senior Research Fellow - Centre for Human Genetics
  5. Panel Discussion: Lived Experience of Medical Nomenclature
    Live Lounge Stage
    Speakers
    Sarah Wynn
    Sarah Wynn, Chief Executive Officer - Unique 
    Francesca Wicks
    Francesca Wicks, Information Officer - Unique 
    Sasha Henriques
    Sasha Henriques, Principal Genetic Counsellor - Guy's and St Thomas NHS Foundation Trust
    Tootie Bueser
    Tootie Bueser, Chief Nurse - South East Genomic Medicine Service
    Emma Tomlinson
    Emma Tomlinson, Specialist Midwife - Tommy's Rainbow Clinic
    Alex Davey
    Alex Davey, Parent of a Child with a Rare Disease
  6. When Every Sample Is Different: Automation strategies for Highly Variable Genomic Workflows
    Live Lounge Stage
    Speakers
    Piotr Cuber
    Piotr Cuber, Senior Molecular Biologist, Robotics - Natural History Museum
    Yuen Chan
    Yuen Chan, Senior Automation Scientist and Molecular Biologist - Natural History Museum
  7. Quantifying the invisible – ddPCR in liquid biopsy-based MRD monitoring
    Live Lounge Stage
    Speakers
    Kelly Sillence
    Kelly Sillence, Regional Application Specialist ddPCR - Bio-Rad Laboratories
  8. Best Practices in Single-cell Sequencing: How to Plan & Validate Experiments
    Live Lounge Stage
    Speakers
    Tom Ayers
    Tom Ayers, Senior Business Development Manager - Single Cell Discoveries
  9. Latest Insights in NGS-based MRD Detection: Learnings from a Retrospective AML Cohort Study
    Live Lounge Stage
    Speakers
    Graham Speight
    Graham Speight, Executive Vice President – R&D - Oxford Gene Technology
  10. Addressing Health Disparities: The Impact of Workforce Diversity on The Patient Population
    Live Lounge Stage
    Speakers
    Vicki Heath
    Vicki Heath, Chief Healthcare Science Officer - Welsh Government
  11. Panel Discussion: Empowering the Global Genomics Workforce: Building Capacity, Confidence & Community Through GGNET
    Live Lounge Stage
    Speakers
    Jillian Hastings Ward
    Jillian Hastings Ward, Patient Advocate
    Dame Sue Hill
    Dame Sue Hill, Chief Scientific Officer - NHS England
    Kate Tatton Brown
    Kate Tatton Brown, Clinical Director & Head of National Genomics Education - NHS England
  12. Making Genomics Work: Introducing the Mainstream Genetic Counsellor Toolkit
    Live Lounge Stage
    Speakers
    Roberta Rizzo
    Roberta Rizzo, Consultant Genetic Counsellor - Oxford University Hospitals NHS Foundation Trust
  13. Networking Break
    Live Lounge Stage
  14. A Tissue-based Gene Signature Bridges to Saliva for Non-invasive Detection of Early Gastric Cancer
    Live Lounge Stage
    Speakers
    Catarina Lopes
    Catarina Lopes, PhD Student - IPO Porto
  15. Bioinformatics Approaches for Identifying Genetic Contributions to Alzheimer's Disease and Type 2 Diabetes
    Live Lounge Stage
    Speakers
    Kaira Cristina Peralis Tomaz
    Kaira Cristina Peralis Tomaz, PhD Student - Unicamp / The Rosalind Franklin Institute
  16. Panel Discussion: Empowering a Genomics-Ready Workforce
    Live Lounge Stage
    Speakers
    Mark Kristiansen
    Mark Kristiansen, Head of UCL Genomics and Associate Professor (Education) - University College London
    Teodora Popa
    Teodora Popa,  Lecturer - University College London
    Horia Stanescu
    Horia Stanescu, Associate Professor - University College London
    Diego Marín
    Diego Marín, Adjunct Professor - The State University of New Jersey
    Francesca Tonini
    Francesca Tonini, GLH Scientist Educator Lead | East Genomics & Genomics Education Programme Scientific Co-Chair | ACGS Workforce Development Committee Clinical Scientist | HCPC
Genomic Medicine Stage
  1. Taming Titin: Practical Approaches to Interpreting the Giant of Variant Challenges
    Genomic Medicine Stage
    Speakers
    Marco Savarese
    Marco Savarese, Group Leader - Folkhalsan Research Center
  2. Getting It Right: Best Practice Guidelines for Rare Disease Variant Classification in the NHS
    Genomic Medicine Stage
    Speakers
    Miranda Durkie
    Miranda Durkie, Consultant Clinical Scientist, Rare Disease Lead - North East Yorkshire Genomic Laboratory Hub
  3. The Importance of Up-To-Date Dynamic Resources to Enable Accurate Variant Interpretation and Reclassification
    Genomic Medicine Stage
    Speakers
    Sarah Hunt
    Sarah Hunt, Variation Resources Coordinator - EMBL-EBI 
  4. Lunch Break
    Genomic Medicine Stage
  5. Genomic Medicine in Clinical Practice
    Genomic Medicine Stage
    Speakers
    Hannah Knight
    Hannah Knight, Genetic Counsellor, Clinical Feedback Lead - NIHR BioResource
    Denise Barnes
    Denise Barnes, Lead Midwife - North East and Yorkshire Genomic Medicine Service
    Tootie Bueser
    Tootie Bueser, Chief Nurse - South East Genomic Medicine Service
    Tahni-Ann Wilson
    Tahni-Ann Wilson, Genetic Counsellor - Royal Brompton Hospital 
    Emily Dixon
    Emily Dixon, Principal Genetic Counsellor - Royal Free NHS Foundation Trust 
    Anita Murphy
    Anita Murphy, Lead Nurse - East Genomic Medicine Service Alliance 
    Colette Scrace
    Colette Scrace, Lead Nurse, Genomics for Cancer and Rare Diseases - NHS England
    Andrew Pestaille
    Andrew Pestaille, Principal Genetic Counsellor - St George's University Hospitals NHS Foundation Trust
    Marianne Quinn
    Marianne Quinn, Lead Midwife - South East Genomic Medicine Service 
  6. Networking Break
    Genomic Medicine Stage
  7. Theatre Closed
    Genomic Medicine Stage
Advanced Therapies Stage
  1. Advanced Therapies Wales – Driving National Collaboration and Innovation in Advanced Therapy Research and Delivery
    Advanced Therapies Stage
    Speakers
    Steven Conlan
    Steven Conlan, Professor of Molecular and Cell Biology - Swansea University Medical School
  2. Addressing Challenges of Advanced Therapies of Rare Diseases
    Advanced Therapies Stage
    Speakers
    Claire Booth
    Claire Booth, Consultant Paediatric Immunologist - Great Ormond Street Hospital
  3. Developing Gene Therapy for Cystic Fibrosis and Other Respiratory Diseases
    Advanced Therapies Stage
    Speakers
    Uta Griesenbach
    Uta Griesenbach, Professor of Molecular Medicine - Imperial College London
  4. Lunch Break
    Advanced Therapies Stage
  5. An Advanced Non-Viral Gene Delivery Technology Enables Secretion of FVIII From Skeletal Muscle
    Advanced Therapies Stage
    Speakers
    Trevor Smith
    Trevor Smith, VP of Preclinical R&D - Inovio Pharmaceuticals
  6. Horizon Scanning for Advanced Therapies: From Innovation to Patient Access
    Advanced Therapies Stage
    Speakers
    John Spoors
    John Spoors, Programme Director: Commercial, Managed Access and Medicines Policy - NICE
  7. From Uncertainty to Insight in Advanced Therapies: A Welsh Real-World Data Initiative
    Advanced Therapies Stage
    Speakers
    Hannah Crocker
    Hannah Crocker, Advanced Therapies Outcomes Manager - NHS Wales Joint Commissioning Committee
  8. Networking Break
    Advanced Therapies Stage
  9. Panel Discussion: Accelerating Ultra-Personalised Therapies for Rare Genetic Diseases: From Diagnosis to Delivery
    Advanced Therapies Stage
    Speakers
    Deb Lancaster
    Deb Lancaster, Executive Director Scientific Partnership - Genomics England
    Dan O'Connor
    Dan O'Connor, Director, Regulatory Policy & Early Access - ABPI
    Jacqueline Barry
    Jacqueline Barry, Chief Clinical Officer - Cell and Gene Therapy, Catapult
    Karen Skinner
    Karen Skinner, Chief Operating Officer - LifeArc
  10. Theatre Closed
    Advanced Therapies Stage
Women & Children's Health Stage
  1. Early Detection, Prevention and Risk Prediction of Gynaecological Cancers 
    Women & Children's Health Stage
    Speakers
    Aleksandra Gentry-Maharaj
    Aleksandra Gentry-Maharaj, Professor -  University College London
  2. Applying Different Omics Technologies to Predict Adverse Outcomes in Pregnancy
    Women & Children's Health Stage
    Speakers
    Steve Charnock-Jones
    Steve Charnock-Jones, Professor - University of Cambridge
  3. Endometriosis as a Global Public Health |ssue: Leveraging Genomics
    Women & Children's Health Stage
    Speakers
    Krina Zondervan
    Krina Zondervan, Head of Department, Professor of Reproductive & Genomic Epidemiology, Co-Director Endometriosis CaRe Centre - University of Oxford
  4. Lunch Break
    Women & Children's Health Stage
  5. Applications of cfDNA-based Prenatal Testing
    Women & Children's Health Stage
    Speakers
    Asma Khalil
    Asma Khalil, Professor and Consultant Obstetrician and Fetal Medicine Specialist -  St George's Hospital London
  6. Cell Free DNA in Pregnancy: From Fetal Screening to Uncovering Maternal Malignancies
    Women & Children's Health Stage
    Speakers
    Maria Neofytou
    Maria Neofytou, Lecturer - University of Westminster
  7. Implementation of GW-NIPT: challenges and perspectives
    Women & Children's Health Stage
    Speakers
    Robert-Jan Galjaard
    Robert-Jan Galjaard, Clinical Geneticist and Clinical Cytogeneticist -  Erasmus MC
  8. Networking Break
    Women & Children's Health Stage
  9. CycleTrack: Building a world-leading resource for menstrual health research.
    Women & Children's Health Stage
    Speakers
    Lachlan Ford MacBean
    Lachlan Ford MacBean, Postdoctoral Research Fellow - University of Exeter
  10. Panel Discussion: Advancing Women’s Health Through Omics Technologies and Effective Collaboration
    Women & Children's Health Stage
    Speakers
    Joyce Harper
    Joyce Harper, Professor - University College London
    Demetra Georgiou
    Demetra Georgiou, Chair of the British Society of Genomic Medicine and Transformation Manager - NHS
    Lachlan Ford MacBean
    Lachlan Ford MacBean, Postdoctoral Research Fellow - University of Exeter
AI In Healthcare Transformation Stage
  1. Mapping Clusters of Chronic Disease Progression in Electronic Health Records with AI
    AI In Healthcare Transformation Stage
    Speakers
    Thomas Beaney
    Thomas Beaney,  Clinical Research Fellow and GP - The George Institute for Global Health 
  2. Using AI for Deep Phenotyping of Patient Records
    AI In Healthcare Transformation Stage
    Speakers
    Richard Dobson
    Richard Dobson, Professor of Biomedical and Health Informatics - NIHR Maudsley Biomedical Research Centre; King's College London
  3. A Human-Inspired Statistical Framework for Tumour Delineation in Medical Imaging
    AI In Healthcare Transformation Stage
    Speakers
    Surajit Ray
    Surajit Ray,  Professor of Statistics - University of Glasgow 
  4. Lunch Break
    AI In Healthcare Transformation Stage
  5. Agentic AI Reasoning in Biomedicine
    AI In Healthcare Transformation Stage
    Speakers
    André Freitas
    André Freitas, Associate Professor & Research Group Leader -  University of Manchester & IDIAP Research Institute
  6. NHS Genomic AI Network- lessons from accelerating AI adoption in genomic medicine
    AI In Healthcare Transformation Stage
    Speakers
    Alexander Deng
    Alexander Deng, Director - NHS Genomic AI Network
  7. From Ego to Ecosystems: Unleashing Real-World Data to Power Healthcare Transformation
    AI In Healthcare Transformation Stage
    Speakers
    Alexander Bedenkov
    Alexander Bedenkov, Vice President, Global Evidence -  AstraZeneca 
  8. Networking Break
    AI In Healthcare Transformation Stage
  9. Panel Discussion: From Pilots to Practice: How Do We Get AI Into Everyday Care?
    AI In Healthcare Transformation Stage
    Speakers
    Richard Dobson
    Richard Dobson, Professor of Biomedical and Health Informatics - NIHR Maudsley Biomedical Research Centre; King's College London
    Rupa Chilvers
    Rupa Chilvers, Deputy Director for Life Sciences and Innovation - Welsh Government
    Beatrix Fletcher
    Beatrix Fletcher, Head of Digital Transformation - Guy's & St Thomas' NHS Foundation
Workshop Room - Gallery Room SG10
  1. Workshop: Computational Biology Upskilling
    Workshop Room - Gallery Room SG10
    Speakers
    Garima Khandelwal
    Garima Khandelwal, Senior Principal Scientist - GSK
    Naveen Prasad
    Naveen Prasad, Senior Principal Scientist, Computational Biology, Translational Omics - GSK
  2. Workshop: Making Spatial Biology FAIR – Practical Steps
    Workshop Room - Gallery Room SG10
    Speakers
    Jan-Philipp Mallm
    Jan-Philipp Mallm, Head, Single Cell Open Lab - DKFZ German Cancer Research Center
    Amonida Zadissa
    Amonida Zadissa, Associate Director of Informatics - UK Dementia Research Institute
    Michele Bortolomeazzi
    Michele Bortolomeazzi,  Bioinformatician - DKFZ
    Sam Jackson
    Sam Jackson, Founder - IO-FAST 
  3. Networking Break
    Workshop Room - Gallery Room SG10
Genome Dome
  1. Roundtable Discussion: Data Citizenship: Who Owns Your Genome?
    Genome Dome
    Speakers
    Stephan Beck
    Stephan Beck, Emeritus Professor of Medical Genomics | Director -  UCL Cancer Institute | Personal Genome Project UK 
    Natalie Banner
    Natalie Banner, Chief Ethics and Engagement Officer - Genomics England
    Kathleen Lidell
    Kathleen Lidell, Professor of Intellectual Property and Medical Law - University of Cambridge
    Kate Sahan
    Kate Sahan, Research Fellow - The Ethox Centre 
  2. Welcome to the Virtual Lab
    Genome Dome
    Speakers
    Nick Hickson
    Nick Hickson, Scientific Education and Training Lead - South East Genomic Laboratory Hub / Synnovis
    Layla Afkhami
    Layla Afkhami,  Scientific Training Officer (Practice Educator) -  Synnovis, Guy’s Hospital 
  3. Networking Break
    Genome Dome
  4. Genome Dome closed
    Genome Dome